Global Information
회사소개 | 문의 | 위시리스트

중동의 핵산 검사(NAT) 시장 : 매출액 예측, 공급업체의 시장 점유율 및 전략 - 감염증, 유전자질환, 암검사, 법의학적 검사, 친부검사

2017 Middle East Nucleic Acid Testing (NAT) Market: Sales Forecasts, Supplier Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

리서치사 Venture Planning Group
발행일 상품 코드 445417
페이지 정보 영문 1185 Pages
가격
US $ 7,500 ₩ 9,192,000 DataPack
US $ 9,250 ₩ 11,337,000 PDF by E-mail (Local license)
US $ 14,500 ₩ 17,772,000 PDF by E-mail (Global license)


중동의 핵산 검사(NAT) 시장 : 매출액 예측, 공급업체의 시장 점유율 및 전략 - 감염증, 유전자질환, 암검사, 법의학적 검사, 친부검사 2017 Middle East Nucleic Acid Testing (NAT) Market: Sales Forecasts, Supplier Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
발행일 : 페이지 정보 : 영문 1185 Pages

중동 국가의 핵산 검사(NAT) 시장을 분석했으며, 검사 방법(분자진단약 등) 개요 및 현재 기술 수준, 주요 진단약·검사약, 국가별·질환별·검사 방법별 동향 전망(향후 5년간), 주요 공급업체의 개요·제품 포트폴리오·사업 전략, 향후 시장 기회 등을 조사·추산하여 전해드립니다.

1. 목차·도표

2. 국가별 시장 동향

  • 바레인
  • 이란
  • 이라크
  • 이스라엘
  • 요르단
  • 쿠웨이트
  • 레바논
  • 오만
  • 사우디아라비아
  • 아랍에미리트(UAE)

3. 각종 질환용 분자진단약 개발·출시 상황

  • AIDS
  • 아데노바이러스
  • 바르토넬라균
  • 캄필로박터
  • 칸디다
  • 클라미디아
  • 클로스트리듐
  • 코로나바이러스
  • 크립토스포리듐
  • 거대세포바이러스(CMV)
  • 에코바이러스
  • 엔테로바이러스
  • 엡스타인 바 바이러스(EBV)
  • 지아르디아
  • 임질
  • 한타바이러스
  • 헬리코박터
  • 간염
  • 헤르페스
  • 인플루엔자
  • 레지오넬라균
  • 라임병
  • 홍역
  • 수막염
  • 단핵증
  • 볼거리
  • 마이코플라스마
  • 폐렴
  • 호흡기세포융합바이러스(RSV)
  • 로타바이러스
  • 풍진
  • 살모넬라균
  • 패혈증
  • 세균성 이질
  • 연쇄구균
  • 매독
  • 톡소플라스마증
  • 트리코모나스
  • 결핵
  • 유전자질환
KSA 17.03.08

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

- Five-year test volume and sales forecasts

- Strategic profiles of market players and start-up firms developing innovative technologies and products

- Emerging technologies

- Review of molecular diagnostic analyzers

- Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Market Segmentation Analysis

Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer                                 - Paternity Testing/HLA Typing
- Genetic Diseases             - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment,
  including:

- Industrial        - Academic
- Government  - Commercial

- Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA SDA     - NASBA TMA    - SSSR, and others LCR

- Universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

- Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 1,185 pages and 98 tables

Table of Contents

List of Tables

  • Bahrain
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Bahrain
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Bahrain
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Bahrain
  • Molecular Diagnostics Market Forecasts by Application
  • Bahrain
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Iran
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Iran
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Iran
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Iran
  • Molecular Diagnostics Market Forecasts by Application
  • Iran
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Iraq
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Iraq
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Iraq
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Iraq
  • Molecular Diagnostics Market Forecasts by Application
  • Iraq
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Israel
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Israel
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Israel
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Israel
  • Molecular Diagnostics Market Forecasts by Application
  • Israel
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Jordan
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Jordan
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Jordan
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Jordan
  • Molecular Diagnostics Market Forecasts by Application
  • Jordan
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Kuwait
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Kuwait
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Kuwait
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Kuwait
  • Molecular Diagnostics Market Forecasts by Application
  • Kuwait
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Lebanon
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Lebanon
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Lebanon
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Lebanon
  • Molecular Diagnostics Market Forecasts by Application
  • Lebanon
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Oman
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Oman
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Oman
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Oman
  • Molecular Diagnostics Market Forecasts by Application
  • Oman
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Saudi Arabia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Saudi Arabia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Saudi Arabia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Saudi Arabia
  • Molecular Diagnostics Market Forecasts by Application
  • Saudi Arabia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • United Arab Emirates
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • United Arab Emirates
  • Molecular Diagnostics Test Volume Forecasts by Application
  • United Arab Emirates
  • Major Infectious Disease Test Volume Forecasts by Assay
  • United Arab Emirates
  • Molecular Diagnostics Market Forecasts by Application
  • United Arab Emirates
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Major Companies Developing or Marketing AIDS Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Bartonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Candida
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Clostridium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Coronavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Cryptosporidium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Echovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Enterovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Giardia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hantavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Helicobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Influenza
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme
  • Disease Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Measles
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Meningitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mononucleosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mumps
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing RSV
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rotavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rubella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Septicemia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Syphilis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Trichomonas
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer
  • Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular
  • Diagnostic Tests for Genetic Diseases
Back to Top
전화 문의
F A Q